Reuters Health Report: June 27, 2017

Click to View in Browser Tuesday, June 27, 2017 Republican healthcare bill imperiled with 22 million seen losing insurance WASHINGTON (Reuters) - Twenty-two million Americans would lose insurance over the next decade under the U.S. Senate Republican healthcare bill, a nonpartisan congressional office said on Monday, complicating the path forward for the already-fraught legislation. California to list glyphosate as cancer-causing; Monsanto vows fight (Reuters) - Glyphosate, an herbicide and the active ingredient in Monsanto Co's popular Roundup weed killer, will be added to California's list of chemicals known to cause cancer effective July 7, the state's Office of Environmental Health Hazard Assessment (OEHHA) said on Monday. Namibia bans poultry imports from South Africa, Belgium after bird flu outbreaks WINDHOEK (Reuters) - Namibia has suspended poultry imports from South Africa and Belgium with immediate effect following outbreaks of highly contagious H5N8 bird flu in the two countries, its Directorate of Veterinary Services (DVS) said on Tuesday. Talks over boosting Illinois Medicaid payments fail CHICAGO (Reuters) - A U.S. judge should order Illinois to pay Medicaid providers about $1 billion a month to ensure medical care continues for the three million recipients of the health program after talks with the state reached an impasse, according to a court filing on Monday. Whole genome sequencing not ready for routine use: study CHICAGO (Reuters) - A study testing the value of DNA sequencing as part of routine medical care showed that roughly one in five people carried a mutation linked with rare disease, but few actually benefited from that information, researchers reported on Monday. New form of Roche's Esbriet approved in Europe for lung disorder ZURICH (Reuters) - Roche said a new Esbriet tablet formulation was approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF), a fatal condition that causes irreversible, progressive scarring of the lungs. Novartis gets European OK for biosimilar of Amgen's Enbrel ZURICH (Reuters) - Novartis's generics unit Sandoz said the European Commission approved Erelzi, its biosimilar to Amgen's Enbrel, to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis. Twenty-two million Americans would lose health coverage under Senate bill: CBO WASHINGTON (Reuters) - Twenty-two million Americans would lose their health insurance coverage over the next decade under draft legislation unveiled by Senate Republicans last week, the non-partisan Congressional Budget Office said on Monday. Stripping Americans of health insurance could be deadly: study (Reuters Health) - - Health insurance saves lives – that's the conclusion of a report released on Monday, just in time to weigh into the debate among Senate Republicans considering a bill that could strip millions of Americans of coverage. 'Pharma bro' Martin Shkreli heads into fraud trial NEW YORK (Reuters) - Martin Shkreli, the pharmaceutical entrepreneur vilified as the "pharma bro" for raising the price of a life-saving drug by 5,000 percent, will go on trial on Monday for what U.S. prosecutors called a Ponzi-like scheme at his former hedge fund and a drug company he once ran. Related Video Tornado ravages Birmingham, Alabama British forest pumped full of CO2 to test tree absorption A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook